These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 2441836

  • 1. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M, Cognetti F, Dodion P, Wildiers J, Rosso R, Rossi A, Gignoux B, Van Rymenant M, Cortes-Funes H, Dalesio O.
    Cancer; 1987 Sep 15; 60(6):1173-7. PubMed ID: 2441836
    [Abstract] [Full Text] [Related]

  • 2. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
    Clavel M, Vermorken JB, Cognetti F, Cappelaere P, de Mulder PH, Schornagel JH, Tueni EA, Verweij J, Wildiers J, Clerico M.
    Ann Oncol; 1994 Jul 15; 5(6):521-6. PubMed ID: 7522527
    [Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck.
    Rozencweig M, Dodion P, Bruntsch U, Gallmeier W, Clavel M, Gignoux B, Cortes Funes H, Cavalli F, Kirkpatrick A, Dalesio O.
    Cancer; 1984 Oct 15; 54(8):1499-503. PubMed ID: 6206936
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P, Dodion PF, Andry G, Chantrain G, Dor P, Buyse M, Van Houtte P, Lemort M, Haesendonck P, Larsimont D.
    Eur J Surg Oncol; 1989 Dec 15; 15(6):568-74. PubMed ID: 2480922
    [Abstract] [Full Text] [Related]

  • 5. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer.
    Cognetti F, Pinnarò P, Carlini P, Ruggeri EM, Ambesi Impiombato F, Del Vecchio MR, Giannarelli D, Perrino A.
    Cancer; 1988 Jul 15; 62(2):251-61. PubMed ID: 2454721
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A, Cummings G, Al-Sarraf M.
    Cancer; 1983 Aug 01; 52(3):399-403. PubMed ID: 6190548
    [Abstract] [Full Text] [Related]

  • 7. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC, Fabian RL.
    Laryngoscope; 1992 Aug 01; 102(8):901-6. PubMed ID: 1379664
    [Abstract] [Full Text] [Related]

  • 8. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH, Baker SR, Liepman MK, Ensminger WD.
    Med Pediatr Oncol; 1983 Aug 01; 11(1):12-9. PubMed ID: 6188032
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V, Valenza R, Testa A, Borsellino N, Cannata G, Restivo S, Speciale R, Ingria F, Spadafora G, Gebbia N.
    ORL J Otorhinolaryngol Relat Spec; 1994 Aug 01; 56(5):279-82. PubMed ID: 7526312
    [Abstract] [Full Text] [Related]

  • 10. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
    Abele R, Honegger HP, Grossenbacher R, Mermillod B, Kaplan E, Gervasi A, Wolfensberger M, Lehmann W, Cavalli F.
    Eur J Cancer Clin Oncol; 1987 Jan 01; 23(1):47-53. PubMed ID: 2439344
    [Abstract] [Full Text] [Related]

  • 11. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
    King GW, Halpin JJ, Smith RE, Batley F, Schuller DE.
    Cancer Treat Rep; 1979 Jan 01; 63(11-12):1735-8. PubMed ID: 93508
    [Abstract] [Full Text] [Related]

  • 12. Carboplatin-based combination chemotherapy for advanced carcinoma of the cervix.
    Junor E, Davies J, Habeshaw T, Kaye S, Paul J, Rankin E, Reed N, Symonds RP.
    Cancer Chemother Pharmacol; 1991 Jan 01; 27(6):484-6. PubMed ID: 1707350
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW.
    Cancer; 2002 Apr 15; 94(8):2224-31. PubMed ID: 12001121
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin-vincristine-bleomycin therapy in squamous cell carcinoma of the head and neck.
    Amrein PC, Fingert H, Weitzman SA.
    J Clin Oncol; 1983 Jul 15; 1(7):421-7. PubMed ID: 6199477
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck.
    Kish JA, Ensley JF, Jacobs J, Weaver A, Cummings G, Al-Sarraf M.
    Cancer; 1985 Dec 15; 56(12):2740-4. PubMed ID: 3902199
    [Abstract] [Full Text] [Related]

  • 16. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.
    Tobias JS, Monson K, Gupta N, Macdougall H, Glaholm J, Hutchison I, Kadalayil L, Hackshaw A, UK Head and Neck Cancer Trialists' Group.
    Lancet Oncol; 2010 Jan 15; 11(1):66-74. PubMed ID: 19875337
    [Abstract] [Full Text] [Related]

  • 17. [A randomized study comparing cisplatin alone or combined in the palliative treatment of carcinoma of the head and neck. Analysis of a series of 209 patients].
    Chauvergne J, Cappelaere P, Fargeot P, Meeus L, Gary-Bobo J, Klein T, Clavel B, David M.
    Bull Cancer; 1988 Jan 15; 75(1):9-22. PubMed ID: 2451954
    [Abstract] [Full Text] [Related]

  • 18. Therapy of recurrent squamous cell carcinoma of the head and neck using combination vincristine, bleomycin, and methotrexate. A Southwest Oncology Group Study.
    Smith RE, Heilbrun LK, Bottomley RM, Gad-el-Mawla N, Fletcher W.
    Cancer; 1986 Dec 01; 58(11):2382-5. PubMed ID: 2429754
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
    Woods RL, Stewart J, Fox RM, Tattersall MH.
    Cancer Treat Rep; 1979 Dec 01; 63(11-12):1997-9. PubMed ID: 93514
    [Abstract] [Full Text] [Related]

  • 20. Combined polychemotherapy and radiotherapy in advanced inoperable squamous cell carcinoma of the head and neck.
    Rosso R, Merlano M, Scarpati D, Grimaldi A, Bonelli L, Barbieri A.
    Head Neck Surg; 1985 Dec 01; 8(2):74-7. PubMed ID: 2416710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.